Dr Reddy's Laboratories Ltd (STU:RDDA)
€ 13.3 -0.2 (-1.48%) Market Cap: 11.08 Bil Enterprise Value: 10.96 Bil PE Ratio: 23.15 PB Ratio: 3.28 GF Score: 90/100

Q1 2025 Dr Reddy's Laboratories Ltd Earnings Call Transcript

Jul 27, 2024 / 11:00AM GMT
Operator

Ladies and gentlemen, good day, and welcome to Q1 FY25 earnings conference call of Dr. Reddy's Laboratories Limited. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Ms. Richa Periwal. Thank you, and over to you.

Richa Periwal;s Laboratories Limited;IR Executive
Dr. Reddy

'-

Thank you. A very good morning and good evening to all of you, and thank you for joining us today for the Dr. Reddy's quarter one FY25 earnings conference call. We have with us the leadership team of Dr. Reddy's comprising Mr. Erez Israeli, our CEO; Mr. Parag Agarwal, our CFO; Mr. M. V. Narasimham, our Deputy CFO; M. V. Ramana, our CEO for Branded Markets and the entire Investor Relations team.

Earlier during the date, we have released our results and the same is also posted on our website. We will begin the call with opening remarks from the management, following which we'll have the forum open for a Q&A session. Please note that today's call is copyrighted material of Dr.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot